Akebia Therapeutics shares owned by Simplex Trading
Quarter-by-quarter ownership of Akebia Therapeutics shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $276k | 101k | 2.72 |
| 2025-06-30 | $331k | 91k | 3.64 |
| 2025-03-31 | $374k | 195k | 1.92 |
| 2024-12-31 | $256k | 135k | 1.89 |
| 2024-09-30 | $32k | 25k | 1.29 |
| 2024-06-30 | $99k | 97k | 1.02 |
| 2024-03-31 | $311k | 170k | 1.83 |
| 2023-12-31 | $11k | 9.3k | 1.18 |
| 2023-09-30 | $18k | 16k | 1.14 |
| 2023-06-30 | $3.0k | 3.4k | 0.88 |
| 2023-03-31 | $1.0k | 2.4k | 0.42 |
| 2022-12-31 | $999 | 3.0k | 0.33 |
| 2022-09-30 | $4.0k | 14k | 0.28 |
| 2022-06-30 | $3.0k | 10k | 0.29 |
| 2022-03-31 | $113k | 158k | 0.71 |
| 2021-12-31 | $128k | 33k | 3.87 |
| 2021-09-30 | $128k | 33k | 3.87 |
| 2021-06-30 | $125k | 33k | 3.78 |
| 2021-03-31 | $296 | 876 | 0.34 |
| 2020-12-31 | $203 | 725 | 0.28 |
| 2020-09-30 | $238 | 954 | 0.25 |
| 2020-06-30 | $142 | 105 | 1.35 |
| 2020-03-31 | $255 | 337 | 0.76 |
| 2019-12-31 | $212 | 336 | 0.63 |
| 2019-09-30 | $12 | 32 | 0.38 |
| 2019-06-30 | $17 | 37 | 0.46 |
| 2019-03-31 | $57 | 71 | 0.82 |
| 2018-12-31 | $16 | 37 | 0.44 |
| 2018-09-30 | $80 | 92 | 0.88 |
| 2018-06-30 | $31 | 32 | 0.97 |
| 2018-03-31 | $10k | 18 | 555.56 |
| 2017-12-31 | $5.0k | 20 | 250.00 |
| 2017-09-30 | $0 | 20 | 0.00 |
| 2017-06-30 | $2.0k | 96 | 20.83 |
| 2017-03-31 | $4.0k | 63 | 63.49 |
| 2016-12-31 | $13k | 406 | 32.02 |
| 2016-09-30 | $1.0k | 160 | 6.25 |
| 2016-06-30 | $29k | 403 | 71.96 |
| 2016-03-31 | $25k | 200 | 125.00 |
| 2015-12-31 | $13k | 121 | 107.44 |
| 2015-09-30 | $4.0k | 25 | 160.00 |
Top funds holding Akebia Therapeutics
View all funds holding Akebia Therapeutics